XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.55

-2.0%

12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (16482)	11/23/2003 2:51:38 PM
From: Bluegreen	Read Replies (2) of 17367

George, you would think that with the Neuprex impressive safety record the new dose just might go through quickly. Think what MIGHT happen if stellar results are found........I mean if PROFOUND, UNBELIEVABLE results are found like in the Phase II Meningococcemia???????? Only instead of only 26 patients you have 208 patients????? I know you don't think this is significant BUT the FDA has a new head from Texas........where is trial being done????? Where is Girior???? Who found the old man's sunken Japan vessel??? I would think there are ALOT of physicians upset ESPECIALLY alot of pediatric physicians upset about Neuprex not being on the market. IT IS EXTREMELY DIFFICULT FOR A PHYSICIAN TO WATCH AN INFANT DIE FOR LACK OF BPI..........KNOWING THAT A SAFE SUPPLEMENT IS NEUPREX!!!!!!!!!!!!!!!!!!!!!! I just can't believe a hotshot news hound hasn't ran with this story. Can you imagine the possible recognition a news reporter would get if one fleshed out the Subpart E story in regard to the Meningococcemia trial?????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next